These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8737639

  • 1. Confirmation of efficacy of etofibrate against peripheral atherosclerosis in non-human primates which model human lesion types I-VII.
    Fincham JE, Quack G, Wülfroth P, Benadé AJ.
    Arzneimittelforschung; 1996 May; 46(5):519-25. PubMed ID: 8737639
    [Abstract] [Full Text] [Related]

  • 2. The effect of Etofibrate (Lipo-Merz) on "in vitro" cellular immune response and on lipid parameters of men with myocardial infarction and with arteriosclerosis obliterans.
    Horváth M, Varsányl M, Jovanovich N, Romics L, Gerö S.
    Allergol Immunopathol (Madr); 1990 May; 18(2):95-9. PubMed ID: 2371944
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans].
    Dembińska-Kieć A, Kostka-Trabka E, Grodzińska L, Bieroń K, Kedzior A, Basista M, Zmuda A, Trabka E, Slawiński M, Czarnecka H.
    Fortschr Med; 1989 Jul 10; 107(20):450-2. PubMed ID: 2767596
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
    Wolf HR.
    Drugs Exp Clin Res; 1994 Jul 10; 20(3):109-13. PubMed ID: 7956717
    [Abstract] [Full Text] [Related]

  • 6. Effect of etofibrate on the development and the regression of atheromas in a rabbit model of atherosclerosis.
    Betz E, Quack G.
    Vasa; 1990 Jul 10; 19(2):157-60. PubMed ID: 2371790
    [Abstract] [Full Text] [Related]

  • 7. Etofibrate decreases factor VII and fibrinogen levels in patients with polymetabolic syndrome.
    Jastrzebska M, Torbus-Lisiecka B, Pieczul-Mróz J, Chelstowski K, Kopciewicz J, Naruszewicz M.
    Int J Clin Pharmacol Res; 1999 Jul 10; 19(1):19-25. PubMed ID: 10450539
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy and safety of etofibrate in patients with non-proliferative diabetic retinopathy].
    Emmerich KH, Poritis N, Stelmane I, Klindzane M, Erbler H, Goldsteine J, Görtelmeyer R.
    Klin Monbl Augenheilkd; 2009 Jul 10; 226(7):561-7. PubMed ID: 19644802
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Etofibrate treatment alters low density lipoprotein susceptibility to lipid peroxidation.
    Wülfroth P, Richter CM, Burkard M, Huth K, Quack G.
    Drugs Exp Clin Res; 1992 Jul 10; 18(11-12):469-74. PubMed ID: 1308472
    [Abstract] [Full Text] [Related]

  • 11. [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy].
    Dobiásová M, Frohlich J.
    Vnitr Lek; 2000 Mar 10; 46(3):152-6. PubMed ID: 11048517
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Lipid changes of fibrinogen and of platelet aggregation induced by etofibrate].
    Fonseca FA, Novazzi JP, Cendoroglo MS, Duarte M, Almeida Pinto LE, Rabelo LM, da Rocha Martinez TL.
    Arq Bras Cardiol; 1996 Jan 10; 66(1):33-5. PubMed ID: 8731322
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome.
    Hartvigsen K, Binder CJ, Hansen LF, Rafia A, Juliano J, Hörkkö S, Steinberg D, Palinski W, Witztum JL, Li AC.
    Arterioscler Thromb Vasc Biol; 2007 Apr 10; 27(4):878-85. PubMed ID: 17255537
    [Abstract] [Full Text] [Related]

  • 17. Effect of valium (diazepam) on experimental atherosclerosis in roosters.
    Patel DJ, Wong HY, Newman HA, Nightingale TE, Frasinel C, Johnson FB, Patel S, Coleman B.
    Artery; 1982 Apr 10; 10(4):237-49. PubMed ID: 7181670
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet.
    Ramesh E, Elanchezhian R, Sakthivel M, Jayakumar T, Senthil Kumar RS, Geraldine P, Thomas PA.
    Fundam Clin Pharmacol; 2008 Jun 10; 22(3):275-84. PubMed ID: 18485145
    [Abstract] [Full Text] [Related]

  • 20. [Lipanor treatment of atherogenic hyperlipoproteinemia].
    Susekov AV, Tvorogova MG, Arabidze GG, Kukharchuk VV.
    Ter Arkh; 1998 Jun 10; 70(9):57-61. PubMed ID: 9821228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.